The global reproductive genetics market size is expected to reach USD 11.23 Billion at a steady CAGR of 12.3% in 2028, according to latest analysis by Emergen Research.The report studies the factors influencing the growth of the industry in the global market and offers accurate predictions about the growth pattern. The report pays special attention to the key elements of the market, such as drivers, restraints, opportunities, threats, risks, limitations, and other aspects. The report covers a comprehensive analysis of the competitive landscape with a detailed analysis of the company profiles, product portfolio, and business expansion strategies.
Chromosomal abnormalities are responsible for 50% of miscarriages in first trimester. Reproductive genetics identifies embryos without these abnormalities so that they can be used for IVF, thus increasing the likelihood of healthy pregnancy and baby regardless of patient health. It also helps in achieving higher pregnancy rates per transfer, which reduces the need for IVF and results in low cost, time, and stress.
Advancements in genomic technologies and implementation of these technologies in clinical medicine has expanded their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility. Some tests are quite expensive, which deters couples from going ahead with the tests, but as there is a decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the procedure and this is expected to support market growth going ahead.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/695
In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.
Prenatal screening covers a variety of tests doctors recommend for a pregnant patient. Some prenatal screening tests determines the chances a baby may or may not have chromosomal disorders, such as Down Syndrome. Though recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood work.
Next Generation Sequencing (NGS) is a widely accepted genetic testing technology in the prenatal testing arena. NGS is able to detect embryos with unbalanced chromosomal translocations that were not identified earlier. NGS offers better coverage of the chromosomes, higher resolution, and is faster and more affordable.
Single gene disorders are among the most understood genetic disorders due to their inheritance patterns and relatively simple genetic causes. Some of the most common single gene disorders are sickle cell anaemia, hemochromatosis, cystic fibrosis, and Tay-Sachs. Reproductive genetic tests are done to detect the possibility of single gene disorders in babies.
Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.
Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc
The report offers a comprehensive breakdown of the regional analysis of the market and subsequent country-wise analysis. The regional analysis of the market comprises of production volume information, consumption volume and patterns, revenue, and growth rate for the forecast period of 2020-2027. According to the regional analysis, the market is primarily spread over key geographical regions as follows:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report: https://www.emergenresearch.com/request-for-customization/695
Competitive Terrain:
The Global Reproductive Genetics Market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graph, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market at length
Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Laboratory Developed Tests (LDT)
Kits
Reagents and Consumables
Procedure Type Outlook (Revenue, USD Billion; 2018–2028)
Pre-Natal Screening
Pre-Implantation Genetic Testing
Infertility Genetic Testing
Carrier Screening
Technology Outlook (Revenue, USD Billion; 2018–2028)
Next-Generation Sequencing (NGS)
Microarray
Polymerase chain reaction (PCR)
In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018–2028)
Single Gene Disorder
Aneuploidy
Structural Chromosomal Abnormality
Others
Reproductive Genetics Key Coverage of report:
Reproductive Genetics Market share valuations of the segments on a country and global level.
Reproductive Genetics Market share analysis of the major market players.
Opportunities and growth prospects for the new Reproductive Genetics 7 market entrants.
Reproductive Genetics Market forecast for all the segments, sub-segments of the market.
Reproductive Genetics Market Trends (drivers, restraints, opportunities, challenges, threats, investment opportunities, and approvals)
Strategic endorsements in the key business segments on the basis of Reproductive Genetics market valuations.
Competitive landscape mapping of the key development patterns.
Company profiling with detailed strategies, financial details, and recent developments.
Latest supply chain trends and technological advancements.
The report objectives are:
To evaluate Reproductive Genetics status, future forecast, growth opportunity, key market, and key players.
To present the Global Reproductive Genetics development in the different regions of the world.
To strategically study and segment the key players and comprehensively analyze their development plan and strategies.
To define, describe, and forecast the market by product type, market, and key regions.
Overview of the Reproductive Genetics Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the Reproductive Genetics industry
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Read More: https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Related Reports:
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
RNA Transcriptomics Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
The post Reproductive Genetics Market Size by 2027 | Industry Segmentation by Type, Key News and Top Companies Profiles appeared first on Market O Graphics.
